Saturday, April 18, 2020 5:42:39 PM
https://en.yna.co.kr/view/AEN20200417006800320
Even when details of the patent and the specific methodology comes out it wont stop the same people questioning it to doubt its veracity.Then they would want to see it work in person. Even with FDA EUA there will be talk about shipping delays, manufacturing defects, inaccurate test and lazy factory workers that will contribute to the failure of this product.
As for a PnD stock especially if DECN is involved in such a scheme would they not release more fluff PRs to pump it. There has been dead silence since April 7th. Where is the pump? Who is pumping this stock? I don't see it.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM